Journals Cardiovascular & Hematological...

Cardiovascular & Hematological Disorders Drug Targets
Smail Amtaghri, Adil Qabouche, Miloudia Slaoui, Mohamed Eddouks
AIMS: This work aimed to investigate the antihypertensive activity of Ammi visnaga. BACKGROUND: The aqueous extract of Ammi visnaga has traditionally been used to treat hypertension in Morocco. OBJECTIVE: The objective of this investigation was to evaluate the effect of Ammi visnaga aqueous extract (AVAE) on arterial blood pressure, systolic blood pressure (SBP), mean blood pressure (MBP), diastolic blood pressure (DBP), and heart rate (HR) in normotensive and hypertensive rats...
December 19, 2023: Cardiovascular & Hematological Disorders Drug Targets
Hamza Elbouny, Brahim Ouahzizi, Oussama Bekkouch, Amal Bennani, Souliman Amrani, Mhamed Ramchoun, Khalid Sellam, Chakib Alem
BACKGROUND: Thymus atlanticus (Ball) Roussine (T. atlanticus) is traditionally used in the Moroccan high Atlas Mountains to treat several disorders, including cardiovascular disease. In the present study, the lipid-lowering and anti-atherosclerotic activities of the traditionally used aqueous extract of T. atlanticus were evaluated on guinea pigs subjected to chronic hyperlipidemia. METHODS: Animals were given a diet containing 2% cholesterol and 20% lard for 12 weeks...
November 30, 2023: Cardiovascular & Hematological Disorders Drug Targets
Deepti Bandawane, Ashwini Kotkar, Pooja Ingole
BACKGROUND: Insulin resistance (IR) is a condition characterized by reduced sensitivity of body tissues to insulin, leading to impaired regulation of downstream metabolic pathways and elevated blood glucose levels. Diets rich in fructose have been proven to cause insulin resistance in test rats, resulting in decreased insulin sensitivity, particularly in the liver, and compromised disposal of glucose from the body. In the search for effective treatments, Plant-derived formulations have gained popularity because to their ability for treating a variety of ailments...
November 30, 2023: Cardiovascular & Hematological Disorders Drug Targets
Pradeep Kumar Niranjan, Shiv Bahadur
Raised blood pressure is the most common complication worldwide that may lead to atherosclerosis and ischemic heart disease. Unhealthy lifestyles, smoking, alcohol consumption, junk food, and genetic disorders are some of the causes of hypertension. To treat this condition, numerous antihypertensive medications are available, either alone or in combination, that work via various mechanisms of action. Combinational therapy provides a certain advantage over monotherapy in the sense that it acts in multi mechanism mode and minimal drug amount is required to elicit the desired therapeutic effect...
November 30, 2023: Cardiovascular & Hematological Disorders Drug Targets
Lakshita Rao, Bigul Yogeshver Bhardwaj, Mahek Chugh, Ashish Sharma, Rashmi Shah, Neha Minocha, Parijat Pandey
Carvedilol is classified as a second class drug of Biopharmaceutical classification system (BCS), and it is an excellent beta blocker and vasodilating agent. It is used in a diverse range of disease states. Despite having tremendous advantages, the drug cannot be used effectively and productively due to aquaphobicity and poor bioavailability. To overcome this limitation, numerous novel approaches and tactics have been introduced over the past few years, such as Selfmicro emulsifying drug delivery systems (SMEDDS), nanoparticles, solid dispersions and liposomal drug delivery...
November 10, 2023: Cardiovascular & Hematological Disorders Drug Targets
Vivek Mohanty, Shubham Sharma, Sourabh Goswami, Atul Kaushik, Rahul Choudhary, Dharamveer Yadav, Surender Deora, Kuldeep Singh
INTRODUCTION: Recent evidence suggests that systemic inflammation not only plays an important role in the pathogenesis of Acute Coronary Syndrome but also correlates with disease severity. Monocyte-to-high-density lipoprotein cholesterol ratio (MHR), Neutrophil-Lymphocyte Ratio (NLR), and Monocyte-Lymphocyte Ratio (MLR) are novel systemic inflammation markers used for predicting the burden of coronary artery disease (CAD) based on SYNTAX score. This single-center, cross-sectional, observational study compared the association of these novel hematological indices with CAD severity using the SYNTAX Score in ACS patients and aimed to determine the best predictor of the severity of CAD...
November 10, 2023: Cardiovascular & Hematological Disorders Drug Targets
Gayatri Jaising Gadekar, Pranali Anandrao Bhandare, Deepti Dinesh Bandawane
AIM: The research intended to explore the possible nephroprotective potential of the ethyl acetate fraction derived from Acacia catechu leaves against nephrotoxicity brought about by 5-fluorouracil (5-FU) in Wistar rats. BACKGROUND: While possessing strong anticancer properties, 5-FU is hindered in its therapeutic application due to significant organ toxicity linked to elevated oxidative stress and inflammation. OBJECTIVE: The study is undertaken to conduct an analysis of the ethyl acetate fraction of A...
November 8, 2023: Cardiovascular & Hematological Disorders Drug Targets
Mahdi Zahedi, Faezeh Davanloo
BACKGROUND: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global health crisis with significant morbidity and mortality. OBJECTIVE: The aim of this study was to investigate the incidence of COVID-19 in patients undergoing primary percutaneous coronary intervention (PCI) for myocardial infarction and identify associated demographic and clinical characteristics. METHODS: In this study, a retrospective and descriptive cross-sectional design was used to examine all patients (a total of 85) who experienced acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI)...
November 8, 2023: Cardiovascular & Hematological Disorders Drug Targets
Abdulrahman Almesned, Abdullah Alqwaee, Bayan Abusiryeh, Ahmad Almeman
OBJECTIVE: To investigate the effectiveness of the decentralization and virtualization of anticoagulation clinics just before and during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: We conducted a cohort study investigation at Prince Sultan Cardiac Clinics PSCC Qassim region, Saudi Arabia. To evaluate the effectiveness of the virtual coagulation clinic, we calculated the time in therapeutic range (TTR), Morisky score for adherence, and satisfaction...
November 2, 2023: Cardiovascular & Hematological Disorders Drug Targets
Amir Shakarami
INTRODUCTION: Myocardial infarction (MI) is a common disease. Nowadays, progress in the rapid management of acute coronary syndrome (ACS) has resulted in saving time and reduction of MI complications. CASE REPRESENTATION: A 68-year-old male musician with a history of coronary artery disease (CAD), while playing fiddle, complained of severe compressive retrosternal chest pain. In the present study, we report a case of inferior ST-segment elevation MI with a post-angioplasty delusion of persecution...
October 27, 2023: Cardiovascular & Hematological Disorders Drug Targets
Jyotika Grewal, Vijay Kumar, Yashika Gandhi, Hemant Rawat, Ravindra Singh, Arjun Singh, Ch V Narasimhaji, Rabinarayan Acharya, Sujeet K Mishra
Cardiovascular diseases (CVDs) are one of the most prevalent medical conditions of modern era and are one of the primary causes of adult mortality in both developing and developed countries. Conventional medications such as use of aspirin, beta-blockers, statins and angiotensin- converting enzyme inhibitors involve use of drugs with many antagonistic effects. Hence, alternative therapies which are safe, effective, and relatively cheap are increasingly being investigated for the treatment and prevention of CVDs...
October 26, 2023: Cardiovascular & Hematological Disorders Drug Targets
Omar Mohammed Ali Saleh Al Qarawani, Palwinder Kaur, Manish Vyas, Sandeep Sharma
BACKGROUND: The global burden of atherosclerosis and its implication to cause coronary heart disease and ischemic cardiac problems is the most prevalent cause of morbidity and hospitalization. In the US, there has been an increase in the number of patients with cardiac problems in the last decade, and still remains the primary cause of death in Europe as well as in the US. OBJECTIVES: Even though therapeutic interventions and early diagnosis the formation of the fatty lesion and its subsequent steps are possible, the therapeutic management of the disease remains questionable when clinical data is observed...
October 5, 2023: Cardiovascular & Hematological Disorders Drug Targets
Mojtaba Ahmadinejad, Ali Soltanian, Haleh Pak, Maryam Zolfaghari, Izadmehr Ahmadinejad
BACKGROUND: This study aims to examine the clinical characteristics and prognosis of patients with chest trauma who were infected with COVID-19 and underwent emergency surgery. OBJECTIVE: In light of the COVID-19 pandemic, this research investigates the impact of covid-19 on patients with chest trauma who underwent emergency surgery. METHODS: This retrospective cohort study was conducted on 56 patients with chest trauma in two groups with COVID-19, and no covid who underwent surgery in Shahid Madani Hospital...
October 5, 2023: Cardiovascular & Hematological Disorders Drug Targets
Smail Amtaghri, Adil Qabouche, Miloudia Slaoui, Mohamed Eddouks
AIM: The current study aimed to evaluate the antidiabetic potential of Illicium verum fruits. BACKGROUND: Illicium verum fruits are frequently used by the Moroccan population in the treatment of diabetes. METHODS: The antihyperglycemic effect of the aqueous extract of Illicium verum fruits (AEIVF) in rats was assessed. The effects of AEIVF (20 mg/kg) on glycemia and lipid profile as well as its phytochemical and antioxidant properties were evaluated...
August 23, 2023: Cardiovascular & Hematological Disorders Drug Targets
Masoumeh Ghafarzadeh, Amir Shakarami, Fatemeh Yari
BACKGROUND: Preterm labor is one of the most important causes of hospitalization during pregnancy and can lead to serious complications in neonates. OBJECTIVE: This study aims to compare the effect of transdermal nitroglycerin (TNG) patches and sublingual tablets of Isosorbide dinitrate (ISD) for the prevention of preterm delivery. METHODS: A total of 110 healthy pregnant women aged 18-35 years with a healthy and alive fetus and gestational age between 24-34 weeks who had at least 8 regular uterine contractions per hour were included in this single-blinded clinical trial...
August 18, 2023: Cardiovascular & Hematological Disorders Drug Targets
Paolo Mongiello, Raffaele Petti, Andrea Ciaccia, Maria Grazia Morgese, Renato Lombardi
INTRODUCTION: Hypercholesterolemia is one of the main risk factors associated with atherosclerotic cardiovascular disease and coronary heart disease. Statins are the standard cholesterollowering treatment; however, they have shown, in clinical practice, a reduced adherence to therapy (<50%) and a modest achievement of the expected outcomes for treatment. This condition prompt scientific research to develop drugs with different mechanisms of action. In this regard, excellent results have been achieved with therapeutic use of monoclonal antibodies against PCSK9, enzyme involved in recycling of Low density lipoprotein receptors (LDLR) on the hepatocytes surface...
August 10, 2023: Cardiovascular & Hematological Disorders Drug Targets
Adil Qabouche, Ayoub Amssayef, Ismail Bouadid, Nadia Lahrach, Ahmed El-Haidani, Mohamed Eddouks
AIMS: The study aimed to assess the antihyperglycemic and antidyslipidemic activities of Artemisia mesatlantica. BACKGROUND: Artemisia mesatlantica is an endemic plant of Morocco used in traditional medicine as an alternative treatment for diabetes. OBJECTIVE: The study was designed to examine the antihyperglycemic and antidyslipidemicability of aqueous extract of Artemisia mesatlantica (AMAE) in experimental animal models. METHODS: The effect of the single and repeated oral administration (7 days of treatment) of AMAE (60 mg/kg) on blood glucose and lipid profile were assessed in normal and streptozotocin-induced diabetic rats...
August 3, 2023: Cardiovascular & Hematological Disorders Drug Targets
Dinesh Kumar Patel
BACKGROUND: Natural products and their derived pure phytochemicals have enormous potential to treat human disorders and associated secondary complications. Natural products are widely consumed by humans due to their rich phytochemical content, diverse therapeutic potential and cost-effectiveness compared to allopathic medicine. Flavonoids are a well-known class of polyphenolic compounds widely present in the plant kingdom. Tectochrysin is an important class of dietary flavonoids present in foods and fruits...
July 26, 2023: Cardiovascular & Hematological Disorders Drug Targets
Imad Adadi, Rachida El Ayadi, Lhoussain Hajji, Mohamed Eddouks, Hamid El Ibaoui
AIMS: The study aimed to analyze the analgesic activity of Cistus ladanifer L. BACKGROUND: Cistus ladanifer L. is a fragrant shrub of the Cistaceae family widespread in the Mediterranean basin, it has various biological activities, including antidiabetic and antihypertensive effects. OBJECTIVE: The objective of this work was to study the phytochemical profile, the acute toxicity and the analgesic power of the ethanolic extract of the species Cistus ladanifer L...
July 21, 2023: Cardiovascular & Hematological Disorders Drug Targets
Basheer Abdullah Marzoog
Myocardial infarction and its sequalae remain the leading cause of death worldwide. Myocardial infarction (MI) survivors continue to live a poor quality of life due to extinguished heart failure. The post-MI period involves several changes at the cellular and subcellular levels, of which autophagy dysfunction. Autophagy is involved in the regulation of post-MI changes. Physiologically, autophagy preserves intracellular homeostasis by regulating energy expenditure and sources. Furthermore, dysregulated autophagy is considered the hallmark of the post-MI pathophysiological changes, which leads to the known short and long post-MI reperfusion injury sequalae...
May 3, 2023: Cardiovascular & Hematological Disorders Drug Targets
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.